Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Profit After Tax: 2009-2025

Historic Profit After Tax for Ani Pharmaceuticals (ANIP) over the last 17 years, with Sep 2025 value amounting to $26.6 million.

  • Ani Pharmaceuticals' Profit After Tax rose 210.14% to $26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 672.15%. This contributed to the annual value of -$18.5 million for FY2024, which is 198.63% down from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Profit After Tax is $26.6 million, which was up 211.35% from $8.5 million recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year Profit After Tax high stood at $26.6 million for Q3 2025, and its period low was -$24.2 million during Q3 2024.
  • Over the past 3 years, Ani Pharmaceuticals' median Profit After Tax value was $6.2 million (recorded in 2023), while the average stood at $4.6 million.
  • In the last 5 years, Ani Pharmaceuticals' Profit After Tax slumped by 23,506.98% in 2022 and then soared by 1,165.25% in 2024.
  • Ani Pharmaceuticals' Profit After Tax (Quarterly) stood at -$24.1 million in 2021, then surged by 82.42% to -$4.2 million in 2022, then skyrocketed by 127.22% to $1.2 million in 2023, then crashed by 989.70% to -$10.3 million in 2024, then skyrocketed by 210.14% to $26.6 million in 2025.
  • Its Profit After Tax was $26.6 million in Q3 2025, compared to $8.5 million in Q2 2025 and $15.7 million in Q1 2025.